Hyperhomocysteinaemia - A common finding in a psychogeriatric population

European Journal of Clinical Investigation

Volumn 26, Issue 10, 1996, Pages 853-859

  Nilsson, K ^a   Gustafson, L ^a   Faldt R ^a   Andersson, A ^a   Brattstrom L ^b   Lindgren, A ^a   Israelsson, B ^a   Hultberg, B ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

Cobalamin; Folate; Homocysteine; Plasma; Psychogeriatric patients

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DEMENTIA; FEMALE; GERONTOPSYCHIATRY; HOMOCYSTEINE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029827897     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1996.tb02129.x     Document Type: Article

References (39)

1. Mudd SH, Harvey LL, Skovby F. Disorders of transsulfuration. In: Scriver, Beaudet, Sly, Valle, eds. The Metabolic Basis of Inherited Disease, 6th edn. McGraw-Hill Book Co 1989:693-734.
2. Brattström L, Hardebo J, Hultberg B. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984;15:1012-16.
3. Boers GHJ, Smals AGH, Trijbels FJM et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985;313:709-15.
4. Kang SS, Wong PWK, Cook HY, Norusis M, Messer JV. Protein-bound homocysteine a possible risk factor for coronary arten disease. J Clin Invest 1986;77:1482-6.
5. Brattström L, Israelsson B, Norrving B et al. Impaired homocysteine metabolism in early onset cerebral and peripheral occlusive arterial disease effects of pyridoxine and folic acid treatment. Atherosclerosis 1990;81:51-60.
6. Murphy Chutorian DR, Wexman MP, Grieco AJ et al. Methionine intolerance: A possible risk factor for coronary artery disease. J Am Coll Cardiol. 1985;6:725-34.
7. Malinow MR, Kang SS, Taylor LM et al. Prevalence of hyperhomocysteinemia in patients with peripheral arterial occlusive disease. Circulation 1989;79:1180-89.
8. Clarke R, Leslie D, Robinson K et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55.
9. Lindenbaum J, Healton EB, Savage DG et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
10. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990; 76:871-81.
11. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1988;81:466-74.
12. Kang S-S, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism 1987;36:458-62.
13. Brattström L, Israelsson B, Lindgärde F, Hultberg B. Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency. Metabolism 1988; 522-59.
14. Hall CA, Chu R C. Serum homocysteine in routine evaluation of potential vitamin B12 and folate deficiency. Eur J Haematol 1990;45:143-9.
15. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency. I. Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990;34:90-8.
16. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency II. Relative sensitivities of serum cobalamin, methylmalonic acid and total homocysteine concentrations. Eur J Hematol 1990;34:99-107.
17. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994;96:239-46.
18. Nilsson K, Gustafson L, Fäldt R, Andersson A, Hultberg B. Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population. Eur J Clin Invest 1994; 24:600-6.
19. Rosenberg IH, Miller JW. Nutritional factors in physical and cognitive functions of elderly people. Am J Clin Nutr 1992;55: 1237S-1243S.
20. Goodwill JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983;249:2917-21.
21. Bell IR, Edman JS, Miller JW. Relationship of normal serum vitamin B-12 and folate levels to cognitive test performance in subtypes of geriatric major depression. J Geriatr Psychiatr Neurol 1990;3:98-105.
22. Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994;236:633-41.
23. Andersson A, Isaksson A, Brattström L, Hultberg B 1993 Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 1993;39:1590-7.
24. Bottglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 1994;48:137-52.
25. Santhosh-Kumar CR, Hassel KL, Deutsch JC, Kolhouse JF. Are neuropsychiatric manifestations of cobalamin and pyridoxine deficiency mediated through imbalances in excitatory sulfur amino acids? Med Hypotheses 1994;43:239-44.
26. Haworth JC, Dilling LA, Surtees RAH et al. Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet 1993;45:572-6.
27. Malinow MR. Plasma homocysteine and arterial occlusive diseases: A mini-review. Clin Chem 1995;41:173-76.
28. Kang SS, Wong PW, Bock HGO, Horwitz A, Grix A. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Med Genet 1991;48:546-51.
29. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ. Thermolabile, 5,10-metheylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142-50.
30. Regland B, Johansson BV, Gottfries C-G. Homocysteinemia and schizophrenia as a case of methylation deficiency. J Neural Transm (Gen Sect) 1994;98:143-52.
31. Regland B, Johansson BV, Grenfeldt B, Hjelmgren L-T, Medhus M. Homocysteinemia is a common feature of schizophrenia. J Neural Transm (Gen Sect) 1995;100:165-9.
32. Fava M, Rosenbaum JF. Transmethylation and the central nervous system. Acta Neurol Scand 1994;89(Suppl. 154):5-6.
33. Bottglieri T, Hyland K. S-adenosylmethionine levels in psychiatric and neurological disorders: A review. Acta Neurol Scand 1994;89(Suppl. 154):19-26.
34. Do KQ, Herrling PL, Streit P, Cuendo M. Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor. J Neurol Transm 1988;72:185-190.
35. Olney JW. Role of excitotoxins in developmental neuropathology. APMIS 1993 101(Suppl. 40):103-12.
36. Ubbink J B. Vitamin nutrition status and homocysteine: An atherogenic risk factor. Nutr Rev 1994;52:383-93.
37. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270: 2693-8.
38. Selhub J, Jacques PF, Bostom AG. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New Engl J Med 1995;332:286-91.
39. Pancharuniti N, Lewis CA, Sauberlich HE et al. Plasma homocysteine, folate and vitamin B-12 concentrations and risk for early onset coronary artery disease. Am J Clin Nutr 1994;59: 940-8.